Evidence mapPaperPMID 40508164Full record

ReviewInternational journal of molecular sciences2025

Oxidative Stress and Endothelial Dysfunction: The Pathogenesis of Pediatric Hypertension.

Kyle Backston, Jordan Morgan, Samipa Patel, Riddhima Koka, Jieji Hu, Rupesh Raina

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Fabry Disease: A Focus on the Role of Oxidative Stress.Antioxidants (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kyle BackstonCollege of Medicine, Northeast Ohio Medical University, Rootstown, OH 44272, USA.
Jordan MorganCollege of Medicine, Northeast Ohio Medical University, Rootstown, OH 44272, USA.ORCID 0009-0006-6289-809X
Samipa PatelSolon High School, Solon, OH 44139, USA.
Riddhima KokaDepartment of Nephrology, Akron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, OH 44302, USA.
Jieji HuCollege of Medicine, Northeast Ohio Medical University, Rootstown, OH 44272, USA.ORCID 0009-0000-3982-7118
Rupesh RainaDepartment of Nephrology, Akron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, OH 44302, USA.ORCID 0000-0003-3892-8376

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pediatric hypertension is increasingly recognized as a complex condition shaped by both systemic and cellular factors, with oxidative stress emerging as a key driver of vascular dysfunction. In both their primary and secondary forms, reactive oxygen species (ROS) disrupt redox homeostasis, impair endothelial signaling, and promote inflammation and tissue remodeling. Metabolic dysregulation, renal pathology, and early-life stressors contribute to the accumulation of ROS through pathways involving NADPH oxidases, mitochondrial dysfunction, xanthine oxidase activity, and altered arginine metabolism. These mechanisms converge on the vasculature, diminishing nitric oxide bioavailability and promoting hypertensive phenotypes. Beyond disease initiation, redox imbalance influences the response to treatment, surgical outcomes, and long-term cardiovascular risk. By further elucidating these mechanisms, the complex relationship between oxidative stress, vascular biology, and blood pressure regulation in children may be more clearly defined and more effectively targeted in clinical management.

Indexed as

Endothelium, VascularHypertensionOxidative StressAnimalsChildHumansReactive Oxygen SpeciesReactive Oxygen Specieschronic kidney diseaseendothelial dysfunctioninflammationoxidative stresspediatric hypertensionreactive oxygen species (ROS)

Identifiers

PMID40508164
PMCPMC12154540

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.